慢性神经肌肉疾病的疾病修饰疗法的进展
1Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, Ohio.
Seminars in respiratory and critical care medicine
|December 21, 2024
概括
新疗法为神经肌肉疾病提供了希望,改善呼吸功能和生活质量. 虽然一些疾病,如骨髓灰质炎和脊柱肌肉缩显示显著的收益,肌缩性侧面硬化症仍然是一个挑战.
科学领域:
- 神经学 神经学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经肌肉疾病经常导致呼吸系统受损,导致严重的发病率和死亡率.
- 最近的进展为各种神经肌肉疾病引入了新的疾病修饰疗法.
- 这些新疗法旨在预防和减轻呼吸道并发症.
研究的目的:
- 审查最近在治疗影响呼吸的神经肌肉疾病方面的治疗进展.
- 突出新批准的治疗方法的疗效,用于肌痛性肌痛,脊髓肌肉缩,晚发佩病和肌缩性侧面硬化.
主要方法:
- 对最近FDA批准的神经肌肉疾病的疾病修饰疗法的审查.
- 对治疗机制的分析,包括补体系统抑制,FcRn阻断,基因剪接调制,基因替代和酶替代.
- 评估临床结果,重点关注呼吸功能,运动功能和疾病进展.
主要成果:
- 对于肌痛性肌痛症,新型疗法如efgartigimod,ravulizumab,rozanolixizumab和zilucoplan向ACHR或MuSK抗体,显示出显著的临床改善.
- 脊柱肌缩治疗,包括nusinersen,risdiplam和onasemnogene abeparvovec,可以提高SMN蛋白水平,从而带来显著的功能增长.
- 晚期爆发的庞培病显示,使用阿瓦尔葡萄糖酶α和 cipaglucosidase alfa/miglustat,呼吸和运动功能得到改善.
- 肌缩性侧面硬化症的治疗提供了适度的益处,在某些患者中减缓了进展.
结论:
- 最近的治疗突破已经显著改善了患有骨髓灰质炎,脊柱肌肉缩和晚发庞培病的患者的治疗结果.
- 这些进展为管理呼吸道并发症和提高生活质量提供了新的希望.
- 肌缩性侧面硬化症的治疗仍然是一个需要进一步发展的领域,以阻止疾病的进展.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
01:28Disorders of the Skeletal Muscle
871
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
871
01:15Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
01:15Myasthenia Gravis: Diagnostic Tests
642
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
642
01:31Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
01:28Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K